Paper of the MonthEAN NewsFeatured Slider
Paper of the month: Stem cell transplantation vs continued disease-modifying therapy in patients with relapsing-remitting multiple sclerosis
For March 2019, we have selected: Burt RK Balabanov, MD Burman J, et al. Effect of nonmyeloablative haematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis. JAMA 2019;321(2):165-174.
Stem cells are a highly topical research area in clinical neurology. Approaches vary from attempts at nerve regeneration to exploitation of immunological effects.










by Anna Sauerbier
Development of multiple sclerosis policy report and national brain plans with a focus on MS, a European Brain Council & Health Policy Partnership 2018–2019 Joint Project
https://www.braincouncil.eu/activities/news/MSpolicynarrative
A…